Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
Researchers at UGA engineered a live bacterium to deliver Levodopa steadily from the gut to the brain, alleviating motor deficits in models of Parkinson's disease. This breakthrough could lead to fewer pills, steadier symptom control, and better quality of life for patients.
SourceUniversity of Georgia, College of Veterinary Medicine·JournalCell Host & Microbe·TypeRandomized controlled/clinical trial·DateNov 13, 2025